Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00480 | Lenalidomide | 1 | Withdrawn | 1 |
| DB11850 | Ublituximab | 1 | Withdrawn | 1 |
| DB14989 | Umbralisib | 1 | Withdrawn | 1 |
| DB09053 | Ibrutinib | 2 | Completed | 1 |
| DB09054 | Idelalisib | 2 | Completed | 1 |
| DB09570 | Ixazomib | 2 | Active Not Recruiting | 1 |
| DB15434 | Mosunetuzumab | 2 | Recruiting | 1 |
| DB00075 | Muromonab | 2 | Recruiting | 1 |
| DB08935 | Obinutuzumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |
| DB15102 | Pemigatinib | 2 | Not Yet Recruiting | 1 |
| DB12240 | Polatuzumab vedotin | 2 | Recruiting | 1 |
| DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |